| 1 |
35149547 | The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases. | 2022 Apr 1 |
1 |
| 2 |
34330845 | The PI3K/mTOR Inhibitor Ompalisib Suppresses Nonhomologous End Joining and Sensitizes Cancer Cells to Radio- and Chemotherapy. | 2021 Nov |
1 |
| 3 |
30326402 | Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity. | 2019 Feb |
1 |
| 4 |
31699977 | AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity. | 2019 Nov 7 |
1 |
| 5 |
31759252 | APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells. | 2019 Dec |
2 |
| 6 |
29574068 | Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor. | 2018 Jun |
1 |
| 7 |
30258062 | Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways. | 2018 Sep 26 |
1 |
| 8 |
28821159 | Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin. | 2017 Oct |
4 |
| 9 |
25480831 | DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival. | 2015 Feb 15 |
1 |
| 10 |
24292814 | DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. | 2014 Jan |
1 |
| 11 |
19633683 | The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair. | 2009 Oct 8 |
1 |
| 12 |
18508926 | DNA-ligase IV and DNA-protein kinase play a critical role in deficient caspases activation in apoptosis-resistant cancer cells by using doxorubicin. | 2008 Aug |
4 |
| 13 |
32038792 | Activation Mechanism of Protein Kinase B by DNA-dependent Protein Kinase Involved in the DNA Repair System. | 2008 Sep |
1 |
| 14 |
14966265 | ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage. | 2004 Mar |
2 |
| 15 |
10854324 | Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. | 2000 Jun |
1 |
| 16 |
10454483 | Glutathione conjugate interactions with DNA-dependent protein kinase. | 1999 Sep |
1 |
| 17 |
9679555 | Coordinate changes in expression of protective genes in drug-resistant cells. | 1998 Apr 24 |
1 |
| 18 |
9685611 | Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. | 1998 Jul 23 |
5 |
| 19 |
9406235 | Importance of glutathione and associated enzymes in drug response. | 1997 |
3 |
| 20 |
8619835 | DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by adriamycin. | 1996 Apr 16 |
1 |